Institutional investors including Venture Catalysts, Apollo Hospitals, Inflection Point Ventures, and Lets Venture participated in the seed and angel funding rounds
anani.life, the country’s first and only digital tech-enabled fertility care platform, recently raised INR 8crores in a round of funding led by major institutional investors.
Prominent institutional investors such as Venture Catalysts, Apollo Hospitals, Inflection Point Ventures, and Lets Venture participated in the seed and angel rounds, along with existing investors including 9unicorn and AL.
Tech infrastructure
Speaking on the investment, Janani Co-Founder Nilay Mehrotra commented the organisation is delighted to secure the support of high-profile investors at the early stage of startup.
“We will leverage the funding to strengthen our tech infrastructure and extend our operations to three metro cities. The capital support has come a shot in the arm for us and will help us take a firm step forward in the direction of becoming India’s largest fertility virtual tech clinic that offers all fertility services at the patient’s doorstep,” said Nilay Mehrotra.
Nilay Mehrotra said the confidence shown by the investors in the company comes as a pat in the back and Janani will strive to raise the bar even higher.
The startup will utilise the funding to build its technology stack and initiate full-fledged operations in three metro cities in the country.
Revolutionary offerings
Despite just starting out, Janani has been able to attract big names of investors in such a short span of time, thanks to their revolutionary offerings.
Founded in June 2020 by Nilay Mehrotra, and Dr. SS Vasan, Janani aims to make the process of infertility treatment and assisted fertilisation free of gender biases, and hence more accessible and affordable for the masses.
Leveraging technology to transform the fertility management industry, Janani aims to establish itself as a leading end-to-end digital fertility care service provider.
Diagnostic tests
The start-up distinguishes itself by providing a first of its kind science-backed, the phase-wise answer to the problem of infertility, assisting patients right from conception planning till the end of the pregnancy. All their services including sample collection and diagnostic tests can be accessed from the comfort of the patients’ homes.
Janani has to its credit a strong founding team include Dr. SS Vasan, Ex- Founding Chairman Manipal Fertility Group, and President of South Asian Society of Sexual medicine brings in unparalleled expertise and years of experience on the table, and Co-founder, Nilay Mehrotra, Ex- Founder VC funded CharIoT and SenRa, who was awarded Top 50 CEO by world innovation congress 2018.
Venture Catalysts Cofounder Apoorv Ranjan Sharma added Janani’s founders have drawn on their industry experience to identify some major need-gaps in India’s fertility management landscape.
“The global infertility market is valued at around $36 Billion, with India having more than 30% of the market cap as of now. Combined with the expertise of its founding team, an innovative IP and the first-mover advantage, the startup is perfectly positioned to disrupt the country’s fertility market for the better,” said Apoorv Ranjan Sharma.
Innovative approach
Apoorv Ranjan Sharma said Janani’s innovative approach gives us the confidence that it will lead the way in revolutionising the fight against infertility. “We are committed to supporting its growth and wish them continued success,” said Apoorv Ranjan Sharma.
Inflection Point Ventures Cofounder Mitesh Shah said the are excited to support Janani as it sets off to redefine fertility care in India. Given the expertise of its founding team and its unique offerings, we believe that Janani has greater heights to soar.”
Janani is creating India’s first and only virtual tech-enabled fertility service management platform. Janani is an end to end fertility service provider with brands in place like Janani.life ( A consumer-centric fertility brand), Janani.ai ( a b2b AI product for identification of the right embryo transfer).
